Fundraising FoxDuke Capital Partners — 2021 Investments
3 investments dated 2021 · listed companies and verified rows first · show all
Sparta Biomedical develops chemically engineered cartilage implants built on its Hyalos hydrogel platform, including Karthyx, an MTP hemiarthroplasty device that combines the cartilage-mimicking hydrogel with a titanium fixation technology.
BiotechHealthtechMedical DevicesMadison, US
Dushyanth Surakanti(Executive Officer, Director)inKen Gall(Director)Dimitrios Angelis(Executive Officer, Director)Sean Fontenot(Director)
Co-investorsMedblue
Superb AI provides an industrial AI stack for vision and analytics applications across mobility, security, defense, logistics, and manufacturing.
AI & Machine LearningDeep TechDeveloper ToolsEnterprise SoftwareSaaSSan Francisco, US
Hyun Kim(Founder)inMoonsu Cha(ML Engineer)inJonghyuk Lee(Machine Learning Engineer)inJungkwon Lee(Founder)inHyundong Lee(Founder)inHyunsoo Kim(Founder)
Co-investorsAtinum Investment Co. Ltd.Grant Park VenturesKT investment Inc.KT Strategic Investment Fund 4Point Reyes ManagementPremier Partners+7 more
Ten63 develops drug-discovery technology that combines generative chemistry with quantum-accurate molecular simulation, including BEYOND (a large quantum chemistry model) and Sentinel (a virtual CSO for target selection), to design therapeutics against previously undruggable targets.
AI & Machine LearningBiotechDeep TechDurham, US
Mark A. Hallen(Founder & CTO)inMarcel Frenkel(Founder & CEO)inDamien Petty(Director)inJia Wei Xu(Director)Bruce Donald, PhD(Founder & Chair SAB)
Co-investorsCape Fear BioCapitalDFJ DragonFundDraper AssociatesHatteras Venture PartnersSOSVAbbVie+4 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.